Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Neuroimaging assessment of spasticity developed after acquired brain injuries and multiple sclerosis.
Massive peripheral nerve hypertrophy in a patient with chronic inflammatory demyelinating polyradiculoneuropathy.
[Clinical and magnetic resonance imaging features of neuromyelitis optics with positive anti-nuclear antibody serum].
Hemoglobin as a source of iron overload in multiple sclerosis: does multiple sclerosis share risk factors with vascular disorders?
Energy expenditure during everyday activities - a study comparing people with varying mobility limitations due to multiple sclerosis and healthy controls.
Longitudinal evaluation of cognitive functioning in pediatric multiple sclerosis: report from the US Pediatric Multiple Sclerosis Network.
Latency of multifocal Visual Evoked Potentials in non-optic neuritis eyes of multiple sclerosis patients associated with optic radiation lesions.
Enhanced patient support services improve patient persistence with multiple sclerosis treatment.
Development and validation of the Dutch version of the London Handicap Scale.
Predicting outcome in clinically isolated syndrome using machine learning.
Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis.
Brainstem glioblastoma in a patient with secondary progressive multiple sclerosis.
Vitamin D levels in multiple sclerosis patients: Association with TGF-β2, TGF-βRI, and TGF-βRII expression.
A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+) T cells and Treg function.
Berberine and neurodegeneration: A review of literature.
Gene set differential analysis of time course expression profiles via sparse estimation in functional logistic model with application to time-dependent biomarker detection.
Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series.
Multi-channel registration of fractional anisotropy and T1-weighted images in the presence of atrophy: application to multiple sclerosis.
Fingolimod (FTY720-P) Does Not Stabilize the Blood-Brain Barrier under Inflammatory Conditions in an in Vitro Model.
Intranasal brain delivery of cationic nanoemulsion-encapsulated TNFα siRNA in prevention of experimental neuroinflammation.
Restless legs syndrome in multiple sclerosis.
Oligodendrogenesis in the fornix of adult mouse brain; the effect of LPS-induced inflammatory stimulation.
The Cellular Prion Protein: A Player in Immunological Quiescence.
[Acute transverse myelitis].
Monitoring oligoclonal immunoglobulins in cerebral spinal fluid using microLC-ESI-Q-TOF mass spectrometry.
Pages
« first
‹ previous
…
532
533
534
535
536
537
538
539
540
…
next ›
last »